Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 6/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | SNCA | P37840 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | TTR | P02766 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium SCHEMBL30132355 | 0.97 | GPR35 (0.56) | GPR35MAPK1ALDH1A1HPGDTP53 | |
| Hydrochloric Acid SCHEMBL28623609 | 0.97 | GPR35 (0.56) | GPR35MAPK1ALDH1A1HPGDTP53 | |
| Barium SCHEMBL30132382 | 0.97 | GPR35 (0.56) | GPR35MAPK1ALDH1A1HPGDTP53 | |
| SCHEMBL30427268 | 0.97 | GPR35 (0.56) | GPR35MAPK1ALDH1A1HPGDTP53 | |
| SCHEMBL227018 | 0.92 | GPR35 (0.56) | GPR35MAPK1ALDH1A1HPGDTP53 | |
| SCHEMBL10575433 | 0.92 | SNCA (0.61) | GPR35MAPK1ALDH1A1HPGDTP53 | |
| SCHEMBL16974397 | 0.92 | GPR35 (0.56) | GPR35MAPK1ALDH1A1HPGDTP53 | |
| SCHEMBL11835122 | 0.92 | GPR35 (0.60) | GPR35MAPK1ALDH1A1HPGDTP53 | |
| Methane SCHEMBL27364322 | 0.90 | SNCA (0.59) | GPR35MAPK1ALDH1A1HPGDTP53 | |
| SCHEMBL11809474 | 0.85 | L3MBTL1 (0.59) | GPR35MAPK1ALDH1A1HPGDTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 341 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116899567-B | Embedded carbon-supported iron-based catalyst and preparation method and application thereof | 华东理工大学 | 2025-03-04 | — | — | CN | claimed |
| CN-118059957-B | Pd-Sn intermetallic compound catalyst and preparation method and application thereof | 华东理工大学 | 2024-08-06 | — | — | CN | claimed |
| CN-118059957-A | Pd-Sn intermetallic compound catalyst and preparation method and application thereof | 华东理工大学 | 2024-05-24 | — | — | CN | claimed |
| US-20230355832-A1 | SYSTEM AND METHOD FOR INTEGRATED ENDOLUMINAL EMBOLIZATION AND LOCALIZED DRUG DELIVERY | FARHA SAID KAMAL (US) | 2023-11-09 | — | — | US | claimed |
| CN-116966903-A | M-In 2 O 3 Application of bifunctional catalyst in selective hydrogenation reaction of 4, 6-dinitroresorcinol | 华东理工大学 | 2023-10-31 | — | — | CN | claimed |
| CN-116899567-A | Embedded carbon-supported iron-based catalyst and preparation method and application thereof | 华东理工大学 | 2023-10-20 | — | — | CN | claimed |
| US-20230263888-A1 | MONOCYTES INDUCING ANTIGEN-SPECIFIC TOLERANCE, ENGINEERED MONOCYTES, AND METHOD OF USE THEREOF | MYELOID THERAPEUTICS, INC. | 2023-08-24 | — | — | US | claimed |
| CN-113686993-B | UPLC-MS detection method for nitrophenol substance and derivative thereof | 安徽宁亿泰科技有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-115784943-A | Method for improving preparation selectivity of 2-sulfonic-4, 6-dinitroresorcinol | 中石化南京化工研究院有限公司 | 2023-03-14 | — | — | CN | claimed |
| CN-112552181-B | Preparation method of 4, 6-dinitroresorcinol | 中石化南京化工研究院有限公司 | 2022-07-08 | — | — | CN | claimed |
| US-6359180-B1 | HYDROLYSIS OF 2-SULFONIC ACID-4,6-DINITRORESORCIN | MITSUI CHEMICALS, INCORPORATED (JP) | 2002-03-19 | — | — | US | claimed |
| CN-1276369-A | Process for preparing 4,6-diamino-m-benzenediol | MITSUI CHEMICALS INC (JP) | 2000-12-13 | — | — | CN | claimed |
| EP-1048644-A1 | Process for the preparation of 4,6-diaminoresorcin | Mitsui Chemicals, Inc. (JP) | 2000-11-02 | — | — | EP | claimed |
| EP-0750605-B1 | ONE-STEP PREPARATION OF 4,6-DINITRORESORCINOL FROM RESORCINOL | TOYO BOSEKI (JP) | 1999-10-13 | — | — | EP | claimed |
| US-5371303-A | One-step preparation of 4,6-dinitroresorcinol from resorcinol | THE DOW CHEMICAL COMPANY (US) | 1994-12-06 | — | — | US | claimed |
| EP-0296221-B1 | PROCESS FOR PREPARING 4,6-DINITRORESORCINOL | THE DOW CHEMICAL COMPANY (US) | 1992-05-13 | — | — | EP | claimed |
| EP-0296221-A4 | PROCESS FOR PREPARING 4,6-DINITRORESORCINOL. | STANFORD RES INST INT (US) | 1989-04-24 | — | — | EP | claimed |
| EP-0296221-A1 | PROCESS FOR PREPARING 4,6-DINITRORESORCINOL. | STANFORD RES INST INT (US) | 1988-12-28 | — | — | EP | claimed |
| WO-1988005038-A1 | PROCESS FOR PREPARING 4,6-DINITRORESORCINOL | SRI INTERNATIONAL (US) | 1988-07-14 | — | — | WO | claimed |
| US-4745232-A | NITRATION, PRECIPITATION | SRI INTERNATIONAL (US) | 1988-05-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230355832-A1 | SYSTEM AND METHOD FOR INTEGRATED ENDOLUMINAL EMBOLIZATION AND LOCALIZED DRUG DELIVERY | PLAU, PLAUR, PLAT | GPR35 1656/4885MAPK1 4431/4885ALDH1A1 3914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.